
è±åœã®å»çåŸäºè ãã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãæåŠââã©ãã»ã«ã»ãã©ã³ããä¿¡é Œã®åŽ©å£ã«å¯Ÿããã倿±ºãã ã
å èšäºã¯ãã¡ããã/Click here to read the original artiæ
åœæ°ä¿å¥ãµãŒãã¹ïŒNHSïŒã®çŸå Žè·å¡ã«ããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®æåŠãé廿å€ãèšé²ããããšãåããã©ãã»ã«ã»ãã©ã³ãã¯ããã®æåŠã¯ãçµ±èšäžã®å¶ç¶ãã§ã¯ãªããæ¿åºãè£œè¬æ¥çãåœéä¿å¥æ©é¢ã«ããé·å¹Žã«ãããæ¬ºçã匷å¶ãäžé©åãªç®¡çã«å¯Ÿããæç¢ºãªè¡šæã ãšè¿°ã¹ãã
è±åœã§ã¯æšå¬ãé廿å€ã®å»çåŸäºè ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®ãæåŠãããã¡ãã£ã¢ã¯ãã®æ±ºå®ãç é¢ãæ©èœäžå šã«é¥ããããšå ±ããã
æ¿æ²»è©è«å®¶ã®ã©ãã»ã«ã»ãã©ã³ãã¯èªèº«ã®ããããã£ã¹ããã¹ãã€ã»ããªãŒãã§ãã®åœ±é¿ãææããã
ãç§åŠãä¿¡ããã¹ããªãããªãç§åŠè ãå»çåŸäºè ãã¯ã¯ãã³æ¥çš®ãæåŠããã®ãïŒããšãã©ã³ãã¯åããããã圌ãã ããç¥ãäœããããã®ã ãããïŒããšç¶ããã
è±çŽãã€ãªãŒã»ã¡ãŒã«ã«ãããšãåœæ°ä¿å¥ãµãŒãã¹ïŒNHSïŒè·å¡ã®ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®çã¯10人äž4äººæªæºïŒããã37ïŒ ïŒã§ãå°åã«ãã£ãŠã¯10ïŒ ãäžåãã±ãŒã¹ããã£ãã
ãããåãNHSã¯ãã€ã³ãã«ãšã³ã¶äºé²æ¥çš®SOSããçºä»€ãè·å¡ã®æ¥çš®çäœäžã«ãããåœå±ãæžå¿µãã2025å¹Žã®æ·±å»ãªã€ã³ãã«ãšã³ã¶æµè¡ãããã«æ¿åããæãããããšèŠåããã
ãã©ã³ãã¯ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãžã®ãåçºãã¯è£œè¬æ¥çãæ¿åºãäžçä¿å¥æ©é¢ïŒWHOïŒãªã©ã®åœéæ©é¢ã«ããé·å¹Žã®æ¬ºçãšåŒ·å¶ãåå ã§ãããããããCOVIDã®æ··ä¹±ããžãšã€ãªãã£ããšäž»åŒµããŠããã
ãã¯ã¯ãã³ãã®ãã®ãžã®ä¿¡é Œã®åŽ©å£ã
ãã©ã³ãæ°ã¯ããã®äžä¿¡æã®æ ¹åºã«ã¯ãã¯ã¯ãã³ãã®ãã®ãžã®ä¿¡é Œã®åŽ©å£ãããããšè¿°ã¹ãæå¹æ§ãžã®æžå¿µãè£åéã®æ¯æãã矩ååããã¹ãŠäººã ã®ä¿¡é Œã匱ããŠãããšäž»åŒµããã
圌ã¯8æã«çºè¡šãããã¹ã€ã¹ã®ç ç©¶ãåŒçšããCOVID-19ããŒã¹ã¿ãŒæ¥çš®ãåããå»çåŸäºè ã¯ãæ¥çš®ãæ§ããè ãããã€ã³ãã«ãšã³ã¶æ§çç¶ãçºçãæ¬ å€ãã確çãæå€§70%é«ãããã®å¢å ã¯æ¥çš®çŽåŸã«ããŒã¯ã«éãããšææããã
10æã®ã¶ã»ãã£ãã§ã³ããŒèªã®èª¿æ»ã«ãããšãç±³åœæå€§çŽã®ã¡ãã£ã±ã€ãå»çä¿éºãã©ã³ã®äžã€ããäœæåŸå±€ã®èŠªã«å¯ŸããåäŸã«ã¯ã¯ãã³ãæ¥çš®ãããèŠè¿ããšããŠæ°çŸãã«çžåœã®ã®ããã«ãŒããæ¯çµŠããŠããããšã倿ããã
7æã«ã¯ããããµã¹å·ã¯ãã¯å°å å»çã·ã¹ãã ã®å»åž«åãã¯ã¯ãã³èª¿éå¥çŽãçµ±æ¬ããã©ã€ã¢ã³ã»ãã£ã ããªã³æ°ãã¶ã»ãã£ãã§ã³ããŒã«å¯Ÿããå»åž«ã¯æ£è ã®80ïŒ ä»¥äžãçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCDCïŒã®å°å ã»é幎äºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ãå®äºããå Žåã«è¿œå å ±é ¬ãåŸããšè¿°ã¹ãã
åãã7æã®ãã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºçŽèšäºã§ã¯ãå°å ç§å»ã®çŽåæ°ãä¿éºäŒç€Ÿãšã䟡å€ã«åºã¥ãå¥çŽããçµãã§ãããšå ±ããããããã®å¥çŽã§ã¯ããå»çã®è³ªãã®ææšãšãããç¹å®ã®åºæºãéæããå»çæäŸè ã«è¿œå å ±é ¬ãæ¯æãããã
2021幎10æãäžçäžã®æ¿åºãCOVID-19ã¯ã¯ãã³ã®æ¥çš®ã矩ååããäžããã¥ãŒãšãŒã¯ã®å»åž«å©æããã©ã»ã³ã³ã©ããã¯ãã¯ã¯ãã³é¢é£ã®æå®³äºè±¡ãé£éŠæ¿åºãéå¶ããã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ïŒVAERSïŒã«å ±åããããšãçç±ã«è§£éãããŸããã2024幎ãã³ã³ã©ããã¯ãå ±åæžã®æåºã劚害ãããšããŠãå éçšäž»ã§ããããã§ã¹ã¿ãŒã»ãªãŒãžã§ãã«ã»ãã«ã¹ãæ¿åºã欺ãããšããŠããã®çš®ã®èšŽèšãšããŠã¯åããŠãšãªã蚎èšãèµ·ãããŸããã
ãã©ã³ãæ°ã¯ãCOVID-19 ã¯ã¯ãã³ã®åŒ·å¶ã«ãããäžçäžã®å»åž«ãçè·åž«ãç é¢ã¹ã¿ããã倧ããªææãåãããšè¿°ã¹ããããã€ãŠè±éãšããŠç§°è³ãããŠããäœäžäººãã®å»çåŸäºè ããä¿¡é Œã§ããªãã¯ã¯ãã³æ¥çš®ãæåŠããããã«è·ã倱ããŸããããšåœŒã¯è¿°ã¹ãã
ãã¥ãŒãšãŒã¯å·ã ãã§ããã¯ã¯ãã³æ¥çš®ã®çŸ©ååãåããŠãæšå® 34,000 人ã®å»çåŸäºè ãèŸè·ãè§£éããŸãã¯äžæè§£éãšãªã£ãã
ãå ¬è¡è¡çã®åã®ããšã«åœŒãã®çèšã¯ç Žå£ãããäžæ¹ã§ãæ¿æ²»æå°è ã補è¬äŒç€Ÿã®å¹¹éšã¯èªãã®æ æ²æ·±ããç§°ãåã£ãŠããããšãã©ã³ãæ°ã¯èªã£ãã
ããªã圌ããä¿¡é Œãã¹ããªã®ãïŒã
ãã©ã³ãã«ããã°ãæå¹æ§ãäœäžãå¯äœçšãçŸããã«ãããããããã¯ã¯ãã³ã¡ãŒã«ãŒã¯å¥çŽãç²åŸãç¶ããå©çã貪ãç¶ãããæ¿åºã¯è£œè¬äŒç€Ÿã責任ããå®ããã¯ã¯ãã³ã«ããå¥åº·è¢«å®³ã«å¯ŸããŠè£åããã
é倱ãçããå Žåããã®è²»çšãè² æ ããã®ã¯äŒæ¥ã§ã¯ãªãçŽçšè ã ãšåœŒã¯è¿°ã¹ãã
ãã©ã³ãæ°ã¯2023幎ã®çªçµã§ãäŒæ¥ãçŽçšè ã®è³éãå©çšããŠå±æ©ããå©çãåŸãã±ãŒã¹ãå€ããšææãé£éŠæ¿åºããã¡ã€ã¶ãŒãšã¢ãã«ãã®COVID-19ã¯ã¯ãã³éçºã»è³Œå ¥ãè³éæŽå©ãã以äžãåœæ°ãè²»çšãè² æ ãããªããå©çãå ±æãã¹ãã ããšäž»åŒµããã
ãã¡ã€ã¶ãŒã¯2022幎ã«å£²äžé«1003åãã«ã«å¯Ÿãé廿é«ã®314åãã«ã®å©çãèšäžãäžæ¹ãã«ã»ã²ã€ãã¯ãã¡ã€ã¶ãŒã®ææºå ã§ããããªã³ããã¯ãžã®æè³ã§æ°åãã«ã皌ãã ãšå ±ããããŠããã
ãã©ã³ãã¯ãNHSïŒåœæ°ä¿å¥ãµãŒãã¹ïŒã®çŸå Žè·å¡ã®æå€§90ïŒ ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãæ¥çš®ããŠããªãäºå®ã¯ãçµ±èšã®å¶ç¶ãã§ã¯ãªããããã¯ãè©æ±ºãã ããšææãããã«ããç¶ããïŒ
ã圌ãã®ã¡ãã»ãŒãžã¯ãäœçŸäžãã®äžè¬åžæ°ãæããªãããå£ã«ããªãæããã®ãã®ã ãæã ã¯åãã€ããã匷å¶ãããæŸåããããããã§ä»ããåã³ä¿¡é ŒãããšïŒ
ãç§åŠã¯ãããããã®ãçãã¹ããã®ã ãæ¿åºãšäŒæ¥ã¯æ£å察ãèŠæ±ãããæåŸãèŠæ±ããã®ã ããããŠä»ãæã ã®ä¿¡é Œãè£åã£ãæ©é¢ããããåæ§ç¯ããããšããŠããâŠæã ã¯ã€ãã«ãå¯äžéèŠãªåããæããããã°ãªããªãããªã圌ããä¿¡é Œãã¹ããªã®ãïŒã